Medicinal Genomics
Blair Beach has a diverse work experience. In 2000, Blair joined bhs industries ltd as the Vice President and served in that role until January 2015. From January 2015 to July 2017, Blair worked as a Patient Advocate at Courtagen Life Sciences, Inc. Since August 2017, Blair has been working at Medicinal Genomics Corporation as Customer Support/Inside Sales.
Blair Beach attended Rollins College from 1990 to 1994, where they obtained a Bachelor of Arts (BA) degree in Fine/Studio Arts, with a focus on General studies. Following this, they pursued further education at the University of Wisconsin-Madison, from 1997 to 2000, where they earned a Master of Fine Arts (MFA) degree in Fine/Studio Arts, specializing in Printmaking.
This person is not in any offices
Medicinal Genomics
Medicinal Genomics is pioneering the genomics of medical cannabis and hemp. In 2011, Medicinal Genomics made worldwide headlines for being the first group to decode the Cannabis Genome. An increasing amount of scientific evidence supports the theory that cannabinoid compounds may have numerous medical benefits. Medicinal Genomics has the largestDNA sequence database of the cannabis plant and is well-positioned to design fingerprinting assays for strain genotyping and sequencing services for strain development. In 2011, Medicinal Genomics was acquired by Courtagen Life Sciences, Inc.